Enovis Corp.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Enovis Corp.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
/ 
Frequently asked questions
To buy Enovis Corp. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Enovis Corp. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Enovis Corp. is ENOV:xnys. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Enovis Corp. has its primary listing on New York Stock Exchange. You can trade Enovis Corp. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Enovis Corp. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Enovis Corp. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Enovis Corp. or others.